Free Access
Med Sci (Paris)
Volume 22, Number 5, Mai 2006
Page(s) 472 - 473
Section Nouvelles
Published online 15 May 2006
  1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000: the global picture. Eur J Cancer 2001; 37 (suppl 8) : S4–66. [Google Scholar]
  2. Koutsky LA, Ault KA, Wheeler CM, et al. Proof of principle study investigators. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347 : 1645–51. [Google Scholar]
  3. Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women : a randomised controlled trial. Lancet 2004; 364 : 1757–65. [Google Scholar]
  4. Hanniffy S, Wiedermann U, Repa A, et al. Potential and opportunities for use of recombinant lactic acid bacteria in human health. Adv Appl Microbiol 2004; 56 : 1–64. [Google Scholar]
  5. Cortes-Perez NG, Bermúdez-Humarán LG, Le Loir Y, et al. Mice immunization with recombinant Lactococcus lactis displaying a cell-wall anchored human papillomavirus type 16 E7 protein. FEMS Microbiol Lett 2003; 229 : 37–42. [Google Scholar]
  6. Bermúdez-Humarán LG, Cortes-Perez NG, Alcocer-González JM, et al. An inducible surface presentation system improves cellular immunity against E7 antigen after nasal administration with recombinant lactococci. J Med Microbiol 2004; 53 : 1–7. [Google Scholar]
  7. Bermúdez-Humarán LG, Langella P, Cortes-Perez NG, et al. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect Immun 2003; 71 : 1887–96. [Google Scholar]
  8. Lin KY, Guarnieri FG, Staveley-O’Carroll KF, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 1996; 56 : 21–6. [Google Scholar]
  9. Bermúdez-Humarán LG, Cortes-Perez NG, Lefèvre F, et al. A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J Immunol 2005; 175 : 7297–302. [Google Scholar]
  10. Liu XS, Abdul-Jabbar I, Qi YM, et al. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice. Virology 1998; 252 : 39-45.EDK 25/2/06 [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.